Amarantus Bioscience Holdings Inc (AMBS)

[barcode27]

Not a stupid question at all. I don't have an answer right now. My best guess is that this all ties to the relationship between Amarantus and UMass (through Dr. Schwartz). Maybe UMass went out and found a pharma company to sponsor these studies once preliminary data on MANF was looking promising. I'm not sure how any sort of licensing agreement would work (assuming the current studies have positive outcomes and Ono is interesting in doing a deal), but the fact that the MANF patents have held up in court is a very promising sign.